Silver dressing proves safe for tough wounds in new study
NCT ID NCT05690685
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at a silver alginate wound dressing (Silvercel) in 56 adults with chronic or acute wounds that were infected or at high risk. Over 6 weeks, doctors checked wound healing and any side effects. The goal was to confirm the dressing is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Silver alginate wound dressing (Silvercel)
- What this could lead to
- If successful, this confirms the dressing is safe and effective for managing wounds with infection risk or heavy drainage.
- What could go wrong
- This is a small, completed post-market study with only 56 participants, so results may not apply to all wound types or patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRESSURE ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Victoria Hospital
East Grinstead, United Kingdom
-
Royal United Hospital Bath
Bath, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden burden: could depression be common in chronic wound patients?
- Could a simple exercise program speed healing of diabetic foot ulcers?
- A simpler air mattress may prevent bedsores just as well — trial puts it to the test
- Can surgery go green? study measures carbon footprint of common orthopedic operations
- Glow-in-the-Dark wound camera study fizzles out
- New imaging device aims to improve wound measurement